glp-1 bulimia The rapid rise of receptor agonists presents a complex dilemma for clinicians managing patients with eating disorders. While these medications show potential in reducing binge eating behaviors by targeting brain reward Bulimia nervosa
Description
Mechanism of action Injectable GLP-1 receptor agonists are synthetic molecules that directly bind to and activate GLP-1 receptors throughout the body
Unopened pens should be stored in a refrigerator at 28C and must not be frozen
The competition Lillys rival oral drug, orforglipron, won FDA approval in April 2026 and is now available in the US
Immunity 42 , 344355 (2015)
Ozempic and Surgery: When to stop and restart
Here is what to know about the new Foundayo GLP-1 pill
